Ibex Partners With HNL to Deploy AI in Cancer Diagnostics

The partnership reflects growing use of AI in pathology to enhance diagnostic accuracy and streamline cancer detection workflows.

Ibex Medical Analytics partnered with HNL Lab Medicine to deploy its AI-powered pathology solutions for cancer diagnostics. The collaboration will integrate the technology into HNL’s workflow to improve diagnostic accuracy and efficiency.

The deployment includes Ibex’s AI solution, Ibex Prostate, designed to analyze prostate biopsies and transurethral resection of the prostate (TURP) samples. The solution aims to support pathologists in detecting cancer more accurately while improving workflow efficiency.

By integrating Ibex’s AI into its digital workflow, HNL Lab Medicine is equipping pathologists with advanced tools to deliver timely and high-confidence diagnostic results.
Yair Heller, CEO, Ibex Medical Analytics.

Ibex Medical Analytics is a clinical-grade pathology platform that uses AI to help pathologists detect, grade and diagnose cancer in breast, prostate and gastric tissues. The platform automates time-consuming manual tasks, reduces human error and improves quality control, helping to minimize diagnostic delays.

Read: Medicine is Not About Algorithms; Responsibility Must Stay With a Human: Surjeet Thakur, TrioTree CEO

The adoption of AI in pathology is growing as diagnostic workflows become more complex and data-intensive. Pathologists are required to analyze large volumes of clinical and genetic data to accurately detect and classify diseases, increasing the need for tools that improve accuracy and efficiency. AI helps automate repetitive tasks, reduce human error and support more precise diagnosis, particularly in cancer detection.

The partnership reflects broader adoption of AI in clinical diagnostics, with healthcare providers increasingly integrating advanced technologies to improve accuracy and efficiency. As digital pathology continues to expand, AI-driven solutions are expected to play a critical role in supporting pathologists, reducing diagnostic delays and enhancing patient outcomes.

The collaboration shows the growing role of AI in transforming pathology workflows, as healthcare systems invest in technologies that enable more precise and scalable diagnostic capabilities.

Disclaimer: This article is based on information from Ibex Medical Analytics’ official announcement. NervNow has not independently verified the claims.

RELATED NEWS
Kleiner Perkins Leads $6M Seed Round in Health Universe
Google AI is Helping Taiwan Predict & Prevent Diabetes at Scale